US Patent 9381186 Substituted chroman derivatives, medicaments and use in therapy
Patent 9381186 was granted and assigned to MEI Pharma on July, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+260 characters)
Article
Patent abstract
Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09381186 Substituted chroman derivatives, medicaments and use in therapy US Patent 9381186 Substituted chroman derivatives, medicaments and use in therapy
Infobox
Patent Number
0938118600
Patent Number
938118600
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093811860
Date of Patent
July 5, 2016
0Patent Application Number
148295070
Date Filed
August 18, 2015
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093811860
Date of Patent
July 5, 2016
0Patent Application Number
148295070
Date Filed
August 18, 2015
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09381186 Substituted chroman derivatives, medicaments and use in therapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09381186
Date of patent
July 5, 2016
Patent application number
14829507
Date Filed
August 18, 2015
Patent primary examiner
Find more entities like US Patent 9381186 Substituted chroman derivatives, medicaments and use in therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.